TCL Archive In Brief: First CREG Announcement Due In Late April For In Vitro Carcinogen Test Improvements March 21, 1975
TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010